Region's lively biotech sector has long way to go
3rd Oct 2005, 04:08 GMT
While much of the attention in the Capital Region for the past five years has been on nanotechnology initiatives, biotechnology projects are starting to make an impact.
Region's lively biotech sector has long way to go related news:
- SFO probe set to hit biotech business — CEN : Top stories
- Growth Areas in Biotech Highlighted at BIO InvestorForum in San Francisco — StratWire - Business of Healthcare NewsFeed
- Human Genome Leads Biotech Stocks Lower — Operations-Related News from StratCenter.com
- BioTech Medics to Commence Marketing 'SHBAN BIOTECH DISINFECTANT & CLEANING SOLUTION' This Fall — Pharmaceuticals News from StratCenter.com
- Q&A: Genzyme’s Alan Smith — Red Herring
- Dr. Wen Jiang: BioTech Nation — ITC: Biotech
- Forscher von Oncolytics Biotech präsentieren Ergebnisse der Studien mit REOLYSIN(R) bei der AACR-NCI-EORTC Konferenz — Presseportal.de Wirtschaft
- Human Genome drags stocks lower — Pharmaceuticals News from StratCenter.com
- Was the 2004 Presidential Election Stolen? Two Experts Face off in Lively Discussion — U.S. Newswire Releases
- SmallCap Sentinel: Innovations in Biotech — Financial News News from StratCenter.com
Latest news from bizjournals.com Health Care:Biotechnology headlines:
- Baylor researchers make heart disease finding
- ZymoGenetics encouraged by early results on lupus treatment
- ActivBiotics shelves IPO plans
- Delta Search Labs spinoff wins Air Force deal for toxin detector
- UTSA joins regional research university alliance on border security
- Intact Medical launches breast cancer detection device